Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Launched by M.D. ANDERSON CANCER CENTER · Sep 28, 2016

Keywords

ClinConnect Summary

This clinical trial is exploring a decision-making tool designed to help women with newly diagnosed breast cancer understand their surgical options, particularly regarding contralateral prophylactic mastectomy. This procedure involves removing the healthy breast as a preventive measure against cancer, and the tool aims to make the decision process easier for patients facing this choice. The study is currently looking for women aged 65 to 74 who have been diagnosed with early-stage breast cancer, such as ductal carcinoma in situ or stages I to III of invasive breast cancer.

To participate in the trial, women must be able to read, write, or speak English and should not have a history of previous breast cancer or prior breast surgeries for prevention. Participants will have the opportunity to use the decision-making tool and share their experiences, which may help improve support for others in similar situations. This trial is an important step in ensuring that patients feel informed and supported as they make significant decisions about their health.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Newly diagnosed ductal breast carcinoma in situ (DCIS) or stage I-III sporadic unilateral invasive breast cancer
• • Able to speak read or write English
• Exclusion Criteria:
• • Patients with previous breast cancer
• • Prior history of bilateral prophylactic mastectomy
• • Known to have a germline mutation that predisposes them to an increased risk of breast cancer (e.g. BRCA1/2) and/or they are considered at high risk for contralateral breast cancer on the basis of a strong family history of cancer